CDDF 12th Spring Conference
Current and Future Challenges of Innovative Oncology Drugs Development
8 – 10 February 2021, Virtual Conference
Presentations
Day 1
Session 1 – Possible Avenues to Speed Up Patient Access
Government/Payer perspective – Anne Willemsen (EUnetHTA, NL)
Patient Perspective – Sabrina Hanna (the cancer collaborative, CA
Academic Perspective – Bert Boer (Erasmus University Rotterdam, NL)
Industry Perspective – Ansgar Hebborn (Roche, CH)
Session 2 – CDDF Workshops in 2021
Why do we have endpoints in clinical trials? – Axel Glasmacher (CDDF, DE)
Day 2
Session 3 – Cancer Drug Development in a Global Setting
Pharmacogenetics in oncology – Ron Mathijssen (Erasmus MC, NL)
Regional matters on the road to global approvals – Irmela Radtke (Roche, CH)
A Regulatory Perspective – Angelo de Claro (FDA, USA)
Session 4 – Advances in Imaging
Radiology imaging – Marion Smits (Erasmus MC, NL)
Molecular imaging – Wim Oyen (Rijnstate Hospital Arnhem and Humanitas Univ Milan, NL)